KLP Kapitalforvaltning’s Core Laboratories CLB Stock Holding History

KLP Kapitalforvaltning’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$97K	Hold	10,000	–	–	﹤0.01%	2083
2026 Q2	$116K	Hold	10,000	–	–	﹤0.01%	2049
2026 Q1	$168K	Hold	10,000	–	–	﹤0.01%	1882
2025 Q4	$160K	Buy	10,000 +1,400	+16%	+$20.8K	﹤0.01%	1915
2025 Q3	$106K	Hold	8,600	–	–	﹤0.01%	2052
2025 Q2	$99.1K	Hold	8,600	–	–	﹤0.01%	2042
2025 Q1	$129K	Hold	8,600	–	–	﹤0.01%	1926
2024 Q4	$149K	Buy	+8,600	New	+$166K	﹤0.01%	1940

Other funds holding CLB

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $2.08B AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Evergreen Capital Management Bellevue, Washington $5.65B AUM 21.62% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

CWA Asset Management Group Naples, Florida $3.39B AUM 25.16% 1-Year Est. Return

KLP Kapitalforvaltning's CLB Position: Q3 2026 in Review

KLP Kapitalforvaltning held its Core Laboratories (CLB) position steady in Q3 2026 at 10,000 shares worth $97K. The position accounts for ﹤0.01% of the portfolio, ranked #2083.

KLP Kapitalforvaltning first reported a position in CLB in Q4 2024 and has held it in 8 quarters since. The position peaked at $168K in Q1 2026. 84 funds tracked by Wall St. Rank hold CLB as of Q3 2026.

KLP Kapitalforvaltning held 10,000 shares of Core Laboratories worth $97K as of Q3 2026.
KLP Kapitalforvaltning left its Core Laboratories share count unchanged in Q3 2026.
Core Laboratories made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q3 2026, its #2083 holding.
KLP Kapitalforvaltning first reported a position in Core Laboratories in Q4 2024 and has held it in 8 quarters since.
KLP Kapitalforvaltning's Core Laboratories position peaked at $168K in Q1 2026.
84 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q3 2026, filed 10 Nov 2026.